Join Binding Site at ASH 2026: Advancing Multiple Myeloma Diagnostics with Mass Spectrometry
About ASH
This December, the Binding Site team will join leading innovators, researchers, and clinicians from around the world at the 2026 American Society of Hematology (ASH) Annual Meeting.
With hundreds of sessions and thousands of abstracts, the ASH annual meeting is the largest hematology conference where the latest clinical advances from around the world are shared.
Why do we attend ASH?
At Binding Site, part of Thermo Fisher Scientific, we are committed to improving patient lives through innovation. Attending ASH enables us to stay up to date with the latest research in Multiple Myeloma and related disorders, and share key information about our portfolio with like-minded experts.
Our recent contribution to Myeloma diagnostics
In 2025, we announced in this press release that Binding Site has received 510(k) clearance for the EXENT™ System to aid in the diagnosis of Multiple Myeloma.
Our team will be at ASH to answer any questions you may have on our innovative automated mass spectrometry solution.
Talk to us about
EXENT System
Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Meet the team
"As the EXENT Mass Spectrometry Global Scientific Affairs lead, my team and I partner with labs and clinicians worldwide to implement mass spectrometry for better patient care in monoclonal gammopathies. Our focus includes guideline compliance, education and research."
Languages spoken: English, Portuguese & Spanish
"As the Field MSL Leader, my focus is to engage with clinicians and laboratorians to discuss the latest developments in the field of monoclonal gammopathies, educate on the utility of Binding Site technologies and to explore novel areas of research using Binding Site products. Using these experiences allows me to help develop educational strategies and share best practices with the global Field MSL team, in order to deliver patient-focussed, guideline-compliant, sensitive and accurate clinical diagnostics."
Languages spoken: English
"As an EXENT MSL, I collaborate with key opinion leaders in the field of hematology to help drive the sustained clinical adoption of the EXENT System for assessing monoclonal gammopathies. One of my main objectives is to educate laboratorians and clinicians about the added benefits of mass spectrometry testing to provide the best care for their patients."
Languages spoken: English
"In my role overseeing Scientific Affairs across North America, I collaborate with clinicians, researchers, and laboratory leaders to help enable scientific discovery and optimize care pathways for patients with plasma cell disorders. Our goal is to drive progress in myeloma care through precise, patient-centered, and guideline-informed diagnostics."
Languages spoken: English
"As an MSL, I partner with clinicians and laboratory leaders to translate plasma cell disorder diagnostics into real-world hematology workflows - empowering healthcare teams to detect, monitor and manage blood cancer patients with greater precision and confidence."
Languages spoken: English, Gujarati & Hindi
"As an MSL, my top priority is ensuring earlier and more accurate monoclonal gammopathy patient diagnosis. In pursuit of this, I work with health systems to educate providers and build solutions to address gaps in guideline compliance."
Languages spoken: English
"As a Medical Affairs leader, I believe that meaningful progress starts with people, curiosity, and collaboration. My passion is to inspire and empower teams, build strong scientific partnerships, and connect innovative science with real-world clinical needs. Together, we can shape the future of plasma cell disorder diagnostics, advance diagnostic excellence, and make a lasting difference in patients' lives."
Languages spoken: English
Resources
*The EXENT™ System combines EXENT™ Analyser with the Immunoglobulin Isotypes (GAM) for the EXENT™ Analyser.
EXENT is a registered trademarks of The Binding Site Group Ltd (Birmingham, UK) in certain countries
© 2026 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific or its subsidiaries.
Product availability is subject to country specific regulatory requirements.
Contact your local representative for availability in your country.